By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.
Cornell startups Ava Labs have new key partnerships with Deloitte and Mastercard, while university startup companies SwiftScale Biologics and Novomer have been acquired.
New nanophotonic tweezers developed by Cornell researchers can stretch and unzip DNA molecules as well as disrupt and map protein-DNA interactions, paving the way for commercial availability.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
The Division of Nutritional Sciences and partner RTI International won a five-year, $23 million award to coordinate research for the NIH’s Nutrition for Precision Health study.
A study also revealed that expanded duties, particularly emotional care, resulted in a higher perceived value of the workers’ contributions, which could help boost pay for home care workers.
As the world enters a third year of pandemic-related uncertainties, one thing does seem certain: The SARS-CoV-2 virus mutates and keeps us on our toes.
A new Cornell-led project will accelerate the application of a proven biotechnology to enhance food and nutritional security in Bangladesh and the Philippines while protecting the health of farmers and the environment.
Dr. Kelly Musick, a Brooks School of Public Policy work-family researcher, has won a prestigious award for an article she co-authored that analyzed earnings patterns after the birth of a child.
